Source: Fortune
A new radar developed with the Gates Foundation and Wellcome Leap reveals that fewer than 3% of clinical trials are women-specific.
Go to Source
Related News
News List
Source: Fortune
A new radar developed with the Gates Foundation and Wellcome Leap reveals that fewer than 3% of clinical trials are women-specific.